<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC2017-2018_S05_ch02_p057-076</title>
		<link href="BCSC2017-2018_S05_ch02_p057-076-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC2017-2018_S05_ch02_p057-076" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>2</p>
			<p class="chapter-title">Neuroimaging in Neuro-Ophthalmology</p>
			<p class="h1 ParaOverride-1">Introduction</p>
			<div id="Chapt2_Top1">
			<p class="body-text--no-indent-">Neuroimaging is an excellent diagnostic and prognostic tool in ophthalmology. However, it should be used in conjunction with, not as a substitute for, a detailed clinical evaluation of the patient. Prior to selecting an appropriate neuroimaging technique, the ophthalmologist should address the following clinical questions:</p>
			<ul>
				<li class="bullet-list-first">What is the clinical presentation?</li>
				<li class="bullet-list-mid">Where is the lesion resulting in the clinical presentation?</li>
				<li class="bullet-list-last">What are the potential etiologies of the lesion?</li>
			</ul>
			<p class="body-text--no-indent-">The choice of imaging modality and the timing of the study should be based on the differential diagnosis, nature of the suspected lesion (eg, vascular), location of the lesion, patient characteristics (eg, age, weight, allergies, comorbidities such as renal function, claustrophobia, presence of metallic foreign bodies or devices such as a pacemaker), and the availability of the desired imaging modality. The ophthalmologist should communicate directly with the neuroradiologist when selecting the best imaging modality and interpreting the neuroimaging study. Errors that the clinician might make when either ordering or reviewing a neuroimaging study fall into 2&#160;broad categories: (1)&#160;prescriptive and (2)&#160;descriptive. <span class="italic">Prescriptive errors</span> include the following:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-2">failure to apply a dedicated study</li>
				<li class="bullet-list-mid">inappropriate use of a dedicated study</li>
				<li class="bullet-list-mid">omission of intravenous contrast material</li>
				<li class="bullet-list-last">omission of specialized sequences</li>
			</ul>
			<p class="body-text--no-indent-"><span class="italic">Interpretive errors</span> include the following:</p>
			<ul>
				<li class="bullet-list-first">failure to detect a lesion due to misleading clinical information</li>
				<li class="bullet-list-mid">rejection of a clinical diagnosis because an expected imaging abnormality is absent</li>
				<li class="bullet-list-mid">the assumption that a striking imaging abnormality accounts for the clinical abnormality</li>
				<li class="bullet-list-last">failure to consider the lack of clinical specificity of an imaging abnormality</li>
			</ul>
			<p class="body-text--no-indent-">This chapter primarily discusses the 2&#160;most common neuroimaging techniques used in neuro-&#173;ophthalmology clinical practice: (1)&#160;<span class="italic">computed tomography (CT)</span> (<span class="xref-figure">Fig&#160;2-1</span>) and (2)&#160;<span class="italic">magnetic resonance imaging (MRI)</span> (<span class="xref-figure">Fig&#160;2-2</span>). In general, most neuro-&#173;ophthalmic diseases are best assessed with MRI of the brain and/or orbits using contrast and fat-&#173;saturation techniques. If a vascular abnormality is suspected, <span class="italic">magnetic resonance angiography (MRA)</span> or <span class="italic">magnetic resonance venography (MRV)</span> can be added to the MRI; <span class="italic">computed tomography angiography (CTA) or computed tomography venography (CTV)</span> can be added to the CT. The use of plain (x-ray) film in the evaluation of neuro-&#173;ophthalmic diseases has largely become obsolete, except to evaluate for a metallic foreign body. A glossary of select neuroimaging terminology appears at the end of this chapter.</p>
			<p class="reference-first ParaOverride-3">Bose S. Principles of neuroimaging in neuro-&#173;ophthalmology. In: Yanoff M, Duker JS, eds. <span class="italic">Ophthalmology.</span> 4th&#160;ed. Philadelphia: Saunders; 2013:851–857.</p>
			<p class="reference-mid">Custer PL, Kent TL. Pitfalls of ophthalmic radiographic imaging. <span class="italic">Curr Opin Ophthalmol.</span> 2014;25(5):432–435.</p>
			<p class="reference-last--no-space-">Lee AG, Johnson MC, Policeni BA, Smoker WR. Imaging for neuro-&#173;ophthalmic and orbital disease—a review. <span class="italic">Clin Exp Ophthalmol.</span> 2009;37(1):30–53.</p>
			</div>
			<p class="h1">Computed Tomography</p>
			<div id="Chapt2_Top2">
			<p class="body-text--no-indent-">The orbit is particularly well suited to x-ray–based CT imaging because fat provides excellent contrast to the globe, lacrimal gland, optic nerve, and extraocular muscles. Bone and lesions that contain calcium can be easily visualized because of their marked x-ray attenuation. Soft-&#173;tissue details can be further enhanced with the injection of iodinated contrast material; this material crosses a disrupted blood–brain barrier and accumulates within a local lesion, revealing inflammatory and neoplastic processes. Iodinated contrast material can be used in patients with a calculated glomerular filtration rate (GFR) greater than 60&#160;mL/min/1.73 m<span class="superscript _idGenCharOverride-1">2</span>.</p>
			<p class="body-text">Most modern CT scanners image the patient with simultaneous sectioning (ie, spiral or helical) and have multiplanar reconstruction capabilities through the use of a volume-&#173;rendering method known as maximum intensity projection (MIP). The advantages of CT include its relatively low cost, rapid image acquisition, wide availability, and excellent spatial resolution. Its speed and ability to accurately identify acute blood or bone abnormalities make CT especially useful when examining trauma patients who may be confused or combative. However, CT scans carry the risk of ionizing radiation. Most national recommendations for dosages are below 150&#160;milliGray (mGy) per scan. The advantages and disadvantages of CT are summarized in <span class="xref-table">Table&#160;2-1</span>.</p>
			</div>
			<p class="h1">Magnetic Resonance Imaging</p>
			<div id="Chapt2_Top3">
			<p class="body-text--no-indent-">As mentioned, MRI is the imaging method of choice for most patients with neuro-&#173;ophthalmic conditions. This technique relies on the magnetic properties of the spinning protons in soft tissue used for image generation. The magnetic field strength is measured in tesla&#160;(T); most commercially available machines range from 1–3&#160;T in strength. Open MRI machines are of lower strength and provide poorer image quality. The superior image quality and shorter acquisition times provided by higher-&#173;strength machines are based on higher-&#173;quality signal-&#173;to-noise and contrast-&#173;to-noise ratios.</p>
			<p class="body-text">MRI is sensitive to changes in the water content of soft tissue, which depends on how the water is bound and how it moves within the tissue. The patient can be injected with gadolinium, a paramagnetic contrast agent with unpaired electrons in the outer shell; the gadolinium traverses a disrupted blood–brain barrier and alters the MRI signal characteristics. This alteration may be crucial in identifying infectious and inflammatory lesions as well as certain tumors with compositions that make them otherwise indistinguishable from normal cortical tissue. Gadolinium-&#173;based contrast agents may cause nephrogenic systemic fibrosis (NSF), a rare, multisystemic disease of the heart, lung, and&#160;liver characterized by soft-&#173;tissue collagen deposition that results in skin thickening and muscle contractures. Gadolinium-&#173;based contrast agents are a relative contraindication in patients with preexisting renal disease and patients who have recently had kidney or liver transplants. Most radiologists will not administer the contrast media if the calculated GFR is lower than 60&#160;mL/min/1.73&#160;m<span class="superscript _idGenCharOverride-1">2</span>. The advantages and disadvantages of MRI are summarized in Table&#160;2-1.</p>
			<p class="body-text">Magnetic resonance images are usually classified as T1- or T2-weighted (<span class="xref-figure">Fig&#160;2-3</span>). Each tissue type has a characteristic T1 and T2 relaxation time attributable to the amount of water in the tissue and how the water is bound in the tissue (<span class="xref-table">Table&#160;2-2</span>). In the most common MRI sequence technique, known as <span class="italic">spin echo (SE),</span> a T1-weighted image is obtained by selecting the appropriate radiofrequency (RF) pulse timing, which is a relatively short time to repetition (TR; approximately 200–700&#160;ms) and a short time to echo (TE; 20–35&#160;ms). The information regarding TR and TE is traditionally displayed on the scan (the position of this information on the display varies according to the image software used). T1-weighted images are optimal for demonstrating anatomy. T1-weighted images also have a higher resolution than T2-weighted images, chiefly because of the increased intensity of the signal and shorter repetition time, which result in faster acquisition times and thereby minimize movement-&#173;related artifacts. However, T2-weighted images (long TR of 1500–3000&#160;ms and TE of 75–250&#160;ms) maximize differences in tissue water content and state and thus are more sensitive to inflammatory, ischemic, or neoplastic alterations in tissue (<span class="xref-figure">Figs&#160;2-4, 2-5, 2-6</span>). Proton density–weighted images are similar to T2-weighted images but have a long TR and a short TE, both of which allow a clear depiction of white versus gray matter; however, proton density–weighted images have now been replaced by <span class="italic">fluid-&#173;attenuated inversion recovery (FLAIR)</span> images.</p>
			<p class="body-text">Very intense tissue signals (eg, those from fat in T1-weighted images and those from cerebrospinal fluid [CSF] or vitreous in T2-weighted images) may obscure subtle signal abnormalities in neighboring tissues (<span class="xref-table">Table&#160;2-3</span>). Special RF pulse sequences are used to reduce such intense signals. Fat-&#173;suppression techniques, such as <span class="italic">short tau inversion recovery (STIR),</span> are used to obtain T1-weighted images without the confounding bright fat signal. This technique is particularly useful in studying the orbit (<span class="xref-figure">Figs&#160;2-7, 2-8</span>; see Fig&#160;2-9D). FLAIR provides T2-weighted images without the high (bright)-CSF signal, making this imaging modality ideal for detecting periventricular white matter changes in a demyelinating process such as multiple sclerosis (<span class="xref-figure">Fig&#160;2-9</span>).</p>
			<p class="body-text"><span class="italic">Diffusion-&#173;weighted imaging (DWI)</span> is sensitive to recent alterations in vascular perfusion and is thus ideal for identifying recent infarctions (<span class="xref-figure">Fig&#160;2-10</span>; see also Fig&#160;2-6). An abnormal DWI signal occurs within minutes of the onset of cerebral ischemia (versus several hours with conventional MRI sequences) and persists for approximately 3&#160;weeks, thus serving as a time marker for acute and subacute ischemic events. <span class="italic">Apparent diffusion coefficient (ADC)</span> is a derived image technique used for stroke and oncological imaging. ADC can help determine whether the DWI hyperintensity is real diffusion restriction or a T2 “shine-through” artifact (see Table&#160;2-3).</p>
			<p class="reference-first">Delouche A, Attyé A, Heck O, et al. Diffusion MRI: pitfalls, literature review and future directions of research in mild traumatic brain injury. <span class="italic">Eur&#160;J Radiol.</span> 2016;85(1):25–30.</p>
			<p class="reference-last--no-space-">Rose TA Jr, Choi JW. Intravenous imaging contrast media complications: the basics that every clinician needs to know. <span class="italic">Am&#160;J Med.</span> 2015;128(9):943–949.</p>
			</div>
			<p class="h1 ParaOverride-4">Vascular Imaging</p>
			<div id="Chapt2_Top4">
			<p class="body-text--no-indent-">Several techniques are commonly used to image blood vessels; obtaining these images is important because of the frequency with which ischemic processes affect the nervous system.</p>
			<p class="h2">Catheter Angiography</p>
			<p class="body-text--no-indent-">The gold standard for intracerebral vascular imaging remains catheter angiography (<span class="xref-figure">Fig&#160;2-11</span>). With this technique, a catheter is placed intra-&#173;arterially and iodinated radiodense contrast dye is injected. <span class="italic">Digital subtraction angiography (DSA)</span> is a technique that reduces artifacts by subtracting densities created by the overlying bony skull. The contrast dye outlines the column of flowing blood within the injected vessel and demonstrates stenosis, aneurysms, vascular malformations, flow dynamics, and vessel wall irregularities such as dissections or vasculitis. The procedure has an overall morbidity of approximately 2.5%, primarily related to ischemia from emboli or vasospasm, dye-&#173;related reactions, or complications at the arterial puncture site (eg, hematoma). The use of digital subtraction technology has enhanced the ability to visualize vascular structures with smaller amounts of contrast dye.</p>
			<p class="h2">Magnetic Resonance Angiography and Magnetic Resonance Venography</p>
			<p class="body-text--no-indent-">Because an MRI signal requires detection of a brief period of excitation and decay, moving tissue often passes out of the plane of assessment before the return signal can be detected, resulting in the black “flow void” that characterizes MRI scans of vascular channels with flow. However, protons that are excited in one slice and then move to another may be specifically imaged using the 3-dimensional assessment technique that underlies MRA and MRV. MRA signals may also be obtained from gadolinium-&#173;enhanced images. This technique is particularly useful for imaging the proximal large vessels of the chest and neck. MRA with gadolinium contrast has a very short acquisition time, reducing the potential for patient movement–related artifacts. MRA provides excellent noninvasive information about large- and medium-&#173;size vessels (<span class="xref-figure">Fig&#160;2-12</span>). Because MRA depends on flow physiology, it tends to overestimate vascular stenosis, and the reduced image resolution limits the ability to visualize smaller vessels or vasculitis. MRV may be helpful in excluding thrombosis within the dural venous sinuses (<span class="xref-figure">Fig&#160;2-13</span>), a condition that may cause papilledema (see Chapter&#160;14).</p>
			<p class="h2">Computed Tomography Angiography and Computed Tomography Venography</p>
			<p class="body-text--no-indent-">CTA uses a high-speed spiral scanner that provides excellent vessel resolution, with 3-dimensional capability that is complementary to that of MRA. The technique requires use of iodinated contrast dye, employs ionizing radiation, and takes approximately 15&#160;minutes to complete. Sensitivities in the detection of aneurysms wider than 3&#160;mm in diameter or stenosis greater than 70% are approximately 95%. Some medical centers prefer the use of CTA to MRA for the detection of cerebral aneurysms, including those causing an ocular motor cranial nerve (CN) palsy (see Chapter&#160;7, Fig&#160;7-9). New multidetector CTA techniques can accurately detect aneurysms greater than 3–4&#160;mm in diameter in nearly all patients with CN&#160;III palsies. CTV is an excellent imaging modality for visualizing the cerebral venous system and is less susceptible to artifacts in comparison to MRV.</p>
			<p class="reference-first">Mathew MR, Teasdale E, McFadzean RM. Multidetector computed tomographic angiography in isolated third nerve palsy. <span class="italic">Ophthalmology.</span> 2008;115(8):1411–1415.</p>
			<p class="reference-last--no-space-">von Kummer R, Dzialowski I, Gerber J. Therapeutic efficacy of brain imaging in acute ische&#173;mic stroke patients. <span class="italic">J&#160;Neuroradiol.</span> 2015;42(1):47–54.</p>
			<p class="h2">Metabolic and Functional Imaging Modalities</p>
			<p class="body-text--no-indent-"><span class="italic">Magnetic resonance spectroscopy (MRS)</span> is used for diagnostic in vivo biochemistry and can provide information about the integrity and metabolism of neural tissue. MRS can help distinguish edema from a tumor. <span class="italic">Functional MRI (fMRI)</span> depends on changes in regional blood flow in the brain in response to performing specific cognitive, sensory, or motor tasks. The biochemical basis of most fMRI techniques is the measurement of differences in blood oxygenation level–dependent (BOLD) responses during performance of these specific tasks. fMRI is useful for intraoperative monitoring and in the evaluation of patients with cortical vision loss. <span class="italic">Positron emission tomography (PET)</span> is performed with the systemic administration of a short–half-life radioisotope, such as fluorodeoxyglucose (FDG), followed by imaging of the positrons produced during their decay. PET shows metabolic perfusion and can detect hypometabolism in patients with visual cortical dysfunction. <span class="italic">Single-&#173;photon emission computed tomography (SPECT)</span> uses an iodinated radiotracer or technetium-99m as a cerebral perfusion and extraction agent. SPECT is more widely available than PET, but it has poorer resolution and specificity. Functional imaging may reveal altered regional cerebral metabolism in patients with cerebral vision impairment from various causes in patients who have a normal MRI.</p>
			<p class="h2">Ultrasonography</p>
			<p class="body-text--no-indent-">Ultrasonography is a noninvasive, relatively inexpensive, rapid, office-&#173;based technique for imaging the globe, orbit, and carotid arteries. The images are based on the reflection of 8–20&#160;MHz (megahertz) ultrasound waves at acoustic interfaces. One form of ultrasonography, <span class="italic">carotid Doppler imaging,</span> is generally accurate at detecting cervical carotid artery stenosis, but it does not provide information about the more proximal or distal vessels. The primary use of carotid Doppler imaging in neuro-&#173;ophthalmology is detection of cervical carotid artery stenosis in patients with transient monocular blindness that is suggestive of retinal or optic nerve ischemia. It is not accurate at detecting carotid artery dissection.</p>
			<p class="body-text"><span class="italic">Orbital Doppler sonography</span> is useful in the evaluation of a suspected carotid-&#173;cavernous fistula by detecting reversal of normally retrograde venous blood flow within the superior ophthalmic vein. Orbital ultrasound provides data concerning the retrobulbar structures, including extraocular muscles, optic nerve, and vessels, but it does not provide accurate imaging of the orbital apex. Ultrasound is also useful for evaluating the optic nerve head (ONH) and can help distinguish ONH edema from ONH drusen; the latter is strongly echogenic (see Chapter&#160;4, Fig&#160;4-22).</p>
			</div>
			<p class="h1 ParaOverride-5">Crucial Questions in Imaging</p>
			<div id="Chapt2_Top5">
			<p class="body-text--no-indent-">Although neuroimaging is widely available, it remains expensive and is not without risks. Accordingly, it is crucial that the clinician addresses the following issues within the context of a specific clinical dilemma when planning the use of an imaging study as part of a neuro-&#173;ophthalmic workup (<span class="xref-table">Table&#160;2-4</span>):</p>
			<ul>
				<li class="bullet-list-first ParaOverride-6"><span class="italic">when</span> to order</li>
				<li class="bullet-list-mid"><span class="italic">what</span> to order<ul><li class="bullet-list-sub-bullet-list _idGenParaOverride-1">modality</li><li class="bullet-list-sub-bullet-list _idGenParaOverride-1">location</li></ul></li>
				<li class="bullet-list-mid"><span class="italic">how</span> to order<ul><li class="bullet-list-sub-bullet-list _idGenParaOverride-1">specify lesion and region of interest</li><li class="bullet-list-sub-bullet-list _idGenParaOverride-1">discuss with radiologist before ordering</li><li class="bullet-list-sub-bullet-list _idGenParaOverride-1">review with radiologist after imaging</li></ul></li>
			</ul>
			<p class="h2">When to Order</p>
			<p class="body-text--no-indent-">The decision concerning when to order an imaging study should be based on clinical localization and the expectation of particular findings. Furthermore, the information acquired by imaging should have some influence on patient management or provide a more accurate prognosis of the disease’s natural history. For those patients with visual symptoms that are believed to herald an emergent neurological or life- or vision-&#173;threatening condition, there should be no delay in performing the necessary testing to confirm the diagnosis and immediately commence treatment.</p>
			<p class="h2">What to Order</p>
			<p class="body-text--no-indent-">With some important exceptions (see Table&#160;2-1), MRI is usually more valuable than CT in detecting a lesion and narrowing the differential diagnosis. The specific choice of imaging modality, including the sequence, orientation, and direction, depends on a combination of the suspected location and the expected pathology. In suspected large-&#173;vessel disease, MRA, CTA, and DSA may also be considered.</p>
			<p class="body-text">Imaging of both the brain and the orbits should be performed. Orbital imaging provides details about the optic nerves and the surrounding tissues that often are not detected with brain imaging alone.</p>
			<p class="body-text">When pathology is localized to the orbit, either CT or MRI can provide useful information. Orbital fat provides excellent contrast with the other orbital components on CT and MRI, and both modalities give excellent anatomical localization (see Figs&#160;2-1, 2-2, 2-5).</p>
			<p class="body-text">Direct coronal images are useful in most orbital disorders (<span class="xref-figure">Fig&#160;2-14</span>). With MRI, direct coronal imaging is not a problem, but CT may require specific positioning (eg, neck extension) that may be difficult to achieve with elderly patients. MRI of the orbit should be done with fat-&#173;saturation techniques designed to eliminate the high-&#173;intensity T1&#160;signal from fat (see Figs&#160;2-7, 2-9D).</p>
			<p class="reference-first">Luccichenti G, Giugni E, Péran P, et al. 3&#160;Tesla is twice as sensitive as 1.5&#160;Tesla magnetic resonance imaging in the assessment of diffuse axonal injury in traumatic brain injury patients. <span class="italic">Funct Neurol.</span> 2010;25(2):109–114.</p>
			<p class="reference-last--no-space-">Mafee MF, Rapoport M, Karimi A, Ansari SA, Shah J. Orbital and ocular imaging using 3-&#160;and 1.5-T MR imaging systems. <span class="italic">Neuroimaging Clin N&#160;Am.</span> 2005;15(1):1–21.</p>
			<p class="h2 ParaOverride-7">How to Order</p>
			<p class="body-text--no-indent-">To obtain the most meaningful neuroimaging results, communication with the neuroradiologist is vital and should include providing a complete patient history, type of scan desired, sequence, contrast material, renal function testing (including the calculated GFR for patients with suspected kidney disease), scan thickness, and area of interest. Failure to supply detailed information often results in images that do not show the area of interest or do so with insufficient detail. Inappropriate images (eg, images showing the wrong location or orientation, lack of contrast administration, or overly thick slices) are often worse than no images at all because they may provide a false sense of security and may create third-party–payer barriers to the required reimaging.</p>
			</div>
			<p class="h1 ParaOverride-8">Negative Study Results</p>
			<div id="Chapt2_Top6">
			<p class="body-text--no-indent-">When an imaging study fails to demonstrate the expected pathology in relation to the clinical presentation, the clinician’s first step is to reexamine the study parameters, ideally with a neuroradiologist. Several questions to keep in mind are:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-9">Were the appropriate studies performed, including required sequences and orientations?</li>
				<li class="bullet-list-mid">Was the area of interest adequately imaged (<span class="xref-figure">Fig&#160;2-15</span>)?</li>
				<li class="bullet-list-last">Are the study results truly negative (<span class="xref-figure">Fig&#160;2-16</span>)?</li>
			</ul>
			<p class="body-text">Even if the ophthalmologist cannot personally review the studies, speaking directly with the radiologist may prevent certain lesions from being overlooked and can provide the clinical information required to enhance the radiographic report’s accuracy and usefulness.</p>
			<p class="glossary-head ParaOverride-10">Glossary of Select Neuroimaging Terminology</p>
			<p class="glossary-entry"><span class="glossary-term">BOLD (blood oxygenation level–dependent)</span> fMRI technique to demarcate areas of high activity in a patient’s brain while the patient performs a specific task.</p>
			<p class="glossary-entry"><span class="glossary-term">CTV (computed tomography venography)</span> CT technique in which the venous vasculature is visualized. It is less susceptible to artifacts in comparison to MRV.</p>
			<p class="glossary-entry"><span class="glossary-term">DWI (diffusion-&#173;weighted imaging) and ADC (apparent diffusion coefficient)</span> MRI techniques used to detect acute and subacute stroke and to differentiate vasogenic from cytotoxic edema.</p>
			<p class="glossary-entry"><span class="glossary-term">FLAIR (fluid-&#173;attenuated inversion recovery)</span> MRI technique that highlights T2-hyperintense abnormalities adjacent to CSF-containing spaces, such as the ventricles, by suppressing CSF signal intensity.</p>
			<p class="glossary-entry"><span class="glossary-term">fMRI (functional magnetic resonance imaging)</span> MRI technique that allows visualization of more active brain areas during a specific task, such as reading.</p>
			<p class="glossary-entry"><span class="glossary-term">Gadolinium</span> Paramagnetic contrast agent administered intravenously to enhance lesions.</p>
			<p class="glossary-entry"><span class="glossary-term">IR (inversion recovery) and TI (interpulse time)</span> MRI pulse sequence that nulls the bright signal of fat or water to create a FLAIR or STIR image. During MRI, initial 180° radiofrequency pulses are followed by a 90° pulse and immediate acquisition of the signal; in IR sequences, the interpulse time is given by TI.</p>
			<p class="glossary-entry"><span class="glossary-term">mGy (milligray)</span> Unit used to measure the absorbed dose of radiation. 1&#160;mGy = 10<span class="superscript _idGenCharOverride-1">–3</span> Gy.</p>
			<p class="glossary-entry"><span class="glossary-term">MRV (magnetic resonance venography)</span> A MRI imaging technique used to visualize the venous vasculature.</p>
			<p class="glossary-entry"><span class="glossary-term">Relaxation</span> Process by which an element releases (re-emits) energy that has been absorbed from the radiofrequency pulses during an MRI sequence.</p>
			<p class="glossary-entry"><span class="glossary-term">SE (spin echo)</span> In the most commonly employed SE sequence, a 180° pulse follows a 90° pulse. For T2-weighted images, the 90° pulse is followed by 2&#160;180° pulses. The first 180° pulse is administered at one-half the TE (time to echo), and the second 180° pulse is administered one full TE later. The “first echo” image is referred to as <span class="italic">proton density,</span> and the “second echo” is T2-weighted.</p>
			<p class="glossary-entry"><span class="glossary-term">STIR (short tau [or TI] inversion recovery)</span> MRI technique that suppresses the bright signal of fat by combining short TI inversion &#173;recovery and a fast SE sequence.</p>
			<p class="glossary-entry"><span class="glossary-term">T1</span> Time required for 63% of protons to return to the longitudinal plane after cessation of a 90° radiofrequency pulse. This is also referred to as the <span class="italic">longitudinal,</span> or <span class="italic">spin-&#173;lattice,</span> relaxation time.</p>
			<p class="glossary-entry"><span class="glossary-term">T2</span> Time required for 63% of the magnetic field in the transverse plane created by the radiofrequency pulse to dissipate. This dispersion of the magnetic vector corresponds to the exchange of spin among protons and is referred to as <span class="italic">spin-spin relaxation;</span> it is completed much more rapidly than is T1 relaxation.</p>
			<p class="glossary-entry"><span class="glossary-term">TE (time to echo)</span> Time following the radiofrequency pulse in which the signal is assessed.</p>
			<p class="glossary-entry"><span class="glossary-term">Tesla</span> The unit of measure of magnetic field strength.</p>
			<p class="glossary-entry-last"><span class="glossary-term">TR (time to repetition)</span> Time following the radiofrequency pulse to repetition of of the pulse.</p>
		</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer003">
				<div id="_idContainer001" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-6273.png" alt="" />
				</div>
				<div id="_idContainer002" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-1</span> Computed tomography (CT) scans. Axial&#160;<span class="figure-caption-bold">(A)</span> and coronal&#160;<span class="figure-caption-bold">(B)</span> orbital views of a healthy subject. <span class="figure-source-note">(Courtesy of Rod Foroozan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00754.png" alt="" />
				</div>
				<div id="_idContainer005" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">F</span><span class="figure-number">igure 2-2</span> Brain and orbital magnetic resonance imaging (MRI) scans showing anatomical visual and orbital structures from the chiasm to the anterior orbit. (The abnormality of the left globe is not pertinent to the objective of this figure.) T1-weighted axial&#160;<span class="figure-caption-bold">(A),</span> T1-weighted coronal&#160;<span class="figure-caption-bold">(B–D),</span> <br />T2-weighted coronal with fat saturation&#160;<span class="figure-caption-bold">(E),</span> and T1-weighted coronal&#160;<span class="figure-caption-bold">(F)</span> images.</p>
					<p class="figure-caption-cont-line"><span class="CharOverride-1">(Continued)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009">
				<div id="_idContainer007" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN007541.png" alt="" />
				</div>
				<div id="_idContainer008" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-2 </span><span class="figure-number CharOverride-2">(continued)</span> ACF = anterior cranial fossa; Ant segment = anterior segment; ICA = internal carotid artery; IO = inferior oblique muscle; IR = inferior rectus muscle; LR = lateral rectus muscle; Lev P = levator palpebrae superioris muscle; MCF = middle cranial fossa; MR&#160;= medial rectus muscle; Olf fossa = olfactory fossa; SO = superior oblique muscle; Sph sinus = sphenoid sinus; Sph wing = sphenoid wing; SR = superior rectus muscle; Temp lobe&#160;= temporal lobe; Vit = vitreous. <span class="figure-source-note">(Courtesy of M. Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer010" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-5" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 2-1</span> Comparison of Magnetic Resonance Imaging and Computed Tomography</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Advantages</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Disadvantages</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Contraindications</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Better able to distinguish white from gray matter</p>
							<p class="table-body">Better able to visualize posterior fossa pathology</p>
							<p class="table-body">Better for soft tissue</p>
							<p class="table-body">Better resolution of optic nerve and orbital apex</p>
							<p class="table-body">Can establish evolution of intraparenchymal hemorrhage</p>
							<p class="table-body">No ionizing radiation</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Contrast dye reactions and systemic nephrogenic fibrosis</p>
							<p class="table-body">Greater cost</p>
							<p class="table-body">Susceptibility artifacts from metal (eg, braces) or air–tissue interfaces</p>
							<p class="table-body">Longer acquisition time</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Cochlear implants</p>
							<p class="table-body">Ferromagnetic implants/foreign bodies</p>
							<p class="table-body">Gadolinium should not be administered in patients who are pregnant</p>
							<p class="table-body">Metallic cardiac valves</p>
							<p class="table-body">Non–MRI-compatible intracranial aneurysm clips</p>
							<p class="table-body">Pacemakers</p>
							<p class="table-body">Renal insufficiency</p>
							<p class="table-body">Technical considerations: claustrophobia/too large for the bore</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Assessment of bony abnormalities</p>
							<p class="table-body">Assessment of orbital and hyperacute intracranial hemorrhage</p>
							<p class="table-body">Detection of calcification in lesions</p>
							<p class="table-body">Evaluation of globe and orbital trauma (include high-resolution bone algorithms)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-6">
							<p class="table-body">Exposure to ionizing radiation dose (CT head radiation dose = 1.5&#160;mGy)</p>
							<p class="table-body">Iodine-based dye contrast reactions</p>
							<p class="table-body">Lack of direct sagittal imaging</p>
							<p class="table-body">Limited resolution <br />in the posterior fossa</p>
							<p class="table-body">Poor resolution of the orbital apex</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Renal insufficiency: Contraindicated if calculated GFR is lower than 60&#160;mL/min/1.73&#160;m<span class="superscript _idGenCharOverride-1">2</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRA/MRV</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Less invasive than catheter angiography</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Limited resolution (in aneurysms ≤3&#160;mm)</p>
							<p class="table-body">May overestimate carotid stenosis or venous sinus stenosis </p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Same as for MRI</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">CTA/CTV </p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Less invasive than catheter angiography</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-9">
							<p class="table-body">Artifacts from superimposed bone and adjacent vessels, especially where aneurysms lie within or close to bone</p>
							<p class="table-body">Limited resolution (in aneurysms ≤3&#160;mm)</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Same as for CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table CellOverride-10" colspan="7">
							<p class="table-footnote ParaOverride-11">CT = computed tomography; CTA = computed tomography angiography; CTV = computed tomography venography; GFR = glomerular filtration rate; mGy = milligray; MRA = magnetic resonance angiography; MRI = magnetic resonance imaging; MRV = magnetic resonance venography.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer013">
				<div id="_idContainer011" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-6276.png" alt="" />
				</div>
				<div id="_idContainer012" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-3</span> Normal axial MRI scans of the brain at the level of the orbits and midbrain, highlighting the different signal characteristics depending on the water content and bound state of the tissue. <span class="figure-caption-bold">A,</span>&#160;T1-weighted image with contrast shows cerebrospinal fluid (CSF) and vitreous as hypointense <span class="figure-caption-italic">(dark),</span> orbital fat as hyperintense <span class="figure-caption-italic">(bright),</span> and gray matter as relatively hypointense in comparison to white matter. <span class="figure-caption-bold">B,</span>&#160;T2-weighted image shows that CSF, vitreous, and orbital fat are hyperintense and gray matter is hyperintense in comparison to white matter. <span class="figure-caption-bold">C,</span>&#160;Fluid-&#173;attenuated inversion recovery image (FLAIR) shows that orbital fat is hyperintense; however, vitreous and CSF appear hypointense, facilitating detection of abnormalities in periventricular tissue. Note that in the FLAIR image the gray matter is lighter than in the T1-weighted image. <span class="figure-source-note">(Courtesy of Rod Foroozan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer014" class="Basic-Text-Frame">
			<table id="table002" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-16" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-6">
						<td class="No-Table-Style _1-BCSC-table-title" colspan="5">
							<p class="table-title"><span class="table-number">Table 2-2</span> MRI Signal Intensity (Brightness) by Tissue Type</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-17">
						<td class="No-Table-Style _4-BCSC-table-body-first-row CellOverride-11" />
						<td class="No-Table-Style _4-BCSC-table-body-first-row CellOverride-11">
							<p class="table-body">T1</p>
						</td>
						<td class="No-Table-Style _4-BCSC-table-body-first-row CellOverride-11" />
						<td class="No-Table-Style _4-BCSC-table-body-first-row CellOverride-11">
							<p class="table-body">Fat &gt; white matter &gt; gray matter &gt; CSF/vitreous &gt; air</p>
						</td>
						<td class="No-Table-Style _4-BCSC-table-body-first-row CellOverride-11" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12">
							<p class="table-body">T2/PD</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12">
							<p class="table-body">CSF/vitreous &gt; gray matter &gt; white matter &gt; fat</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-18">
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12">
							<p class="table-body">FLAIR</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12">
							<p class="table-body">Fat &gt; gray matter &gt; white matter &gt; CSF/vitreous &gt; air</p>
						</td>
						<td class="No-Table-Style _5-BCSC-table-body CellOverride-12" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-19">
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-12" />
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-12">
							<p class="table-body">STIR</p>
						</td>
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-12" />
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-12">
							<p class="table-body">CSF/vitreous = gray matter &gt; white matter &gt; fat &gt; air</p>
						</td>
						<td class="No-Table-Style _7-BCSC-table-body-last-row CellOverride-12" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-20">
						<td class="No-Table-Style _8-BCSC-table-note" colspan="5">
							<p class="table-footnote ParaOverride-11">CSF = cerebrospinal fluid; FLAIR = fluid-attenuated inversion recovery; MRI = magnetic resonance imaging; PD = proton density; STIR = short tau inversion recovery.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer017">
				<div id="_idContainer015" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-5487.png" alt="" />
				</div>
				<div id="_idContainer016" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-4</span> A comparison between T1-weighted and T2-weighted MRI scans can yield information about the characteristics of a lesion and can be particularly helpful in dating hemorrhages. A 61-year-old patient presented with acute onset of severe headache. A hemorrhage is apparent in the parieto-&#173;occipital region in the 3&#160;original scans: T1-weighted&#160;<span class="figure-caption-bold">(A),</span> proton density&#160;<span class="figure-caption-bold">(B),</span> and T2-weighted&#160;<span class="figure-caption-bold">(C)</span> images. The signal at the lesion periphery relates to the presence of&#160;oxyhemoglobin, whereas the core remains dark in all 3&#160;images because of the presence of &#173;deoxyhemoglobin. When the MRI series was repeated 10&#160;days later, the signal characteristics had changed as a result of the development of methemoglobin in the outer ring, which is bright on T1-weighted <span class="figure-caption-bold">(D),</span> proton density&#160;<span class="figure-caption-bold">(E),</span> and T2-weighted&#160;<span class="figure-caption-bold">(F)</span> images. The core remains dark. <span class="figure-source-note">(Courtesy of Steven&#160;A. Newman, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer020">
				<div id="_idContainer018" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-1917.png" alt="" />
				</div>
				<div id="_idContainer019" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-5</span> Various tumors may have specific sequence findings. This patient had a large frontal tumor invading the orbit. <span class="figure-caption-bold">A,</span>&#160;A T1-weighted sagittal sequence shows the tumor to be heterogeneous but mostly hypointense to gray matter. <span class="figure-caption-bold">B,</span>&#160;A gadolinium-&#173;enhanced, T1-weighted axial image demonstrates minimal rim enhancement. <span class="figure-caption-bold">C,</span>&#160;On a proton density image, the signal intensity becomes brighter; it is isointense with gray matter and brighter than white matter. <span class="figure-caption-bold">D,</span>&#160;On a T2-weighted image, the lesion becomes extremely bright. These findings are characteristic of an epidermoid. <span class="figure-source-note">(Courtesy of Steven&#160;A. Newman, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer023">
				<div id="_idContainer021" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00755.png" alt="" />
				</div>
				<div id="_idContainer022" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-6</span> MRI scans of a patient with lateral medullary syndrome (also called Wallenberg syndrome). <span class="figure-caption-bold">A,</span>&#160;A T2-weighted axial MRI scan demonstrates a bright signal in the left lateral medulla <span class="figure-caption-italic">(arrow).</span> <span class="figure-caption-bold">B,</span>&#160;Diffusion-&#173;weighted imaging (DWI) shows a bright signal <span class="figure-caption-italic">(arrow).</span> <span class="figure-caption-bold">C,</span>&#160;The appar-<br />ent diffusion coefficient (ADC) shows a dark signal <span class="figure-caption-italic">(arrow)</span> consistent with an acute infarction and not the phenomenon known as T2 shine-through. <span class="figure-source-note">(Courtesy of M.&#160;Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer024" class="Basic-Text-Frame">
			<table id="table003" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-21" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-23" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-24" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table _1-BCSC-table-title" colspan="5">
							<p class="table-title"><span class="table-number">Table 2-3</span> Edema: DWI and ADC</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">Type of Edema</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head" />
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">DWI Signal</p>
						</td>
						<td class="Basic-Table _3-BCSC-table-column-head" />
						<td class="Basic-Table _3-BCSC-table-column-head">
							<p class="table-column-head">ADC Signal</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-11">
							<p class="table-body">Cytotoxic</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-11" />
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-11">
							<p class="table-body">Bright (high or restricted diffusion)*</p>
						</td>
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-11" />
						<td class="Basic-Table _4-BCSC-table-body-first-row CellOverride-11">
							<p class="table-body">Dark (low)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-12">
							<p class="table-body">Vasogenic</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-12" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-12">
							<p class="table-body">Dark (low)</p>
						</td>
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-12" />
						<td class="Basic-Table _7-BCSC-table-body-last-row CellOverride-12">
							<p class="table-body">Normal (sometimes bright)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table _8-BCSC-table-note" colspan="5">
							<p class="table-footnote">ADC = apparent diffusion coefficient; DWI = diffusion-weighted imaging.</p>
							<p class="table-footnote">*&#9;Bright signal on DWI represents restricted diffusion or decreased water movement.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer027">
				<div id="_idContainer025" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-9371.png" alt="" />
				</div>
				<div id="_idContainer026" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-7</span> MRI scan of a patient with left optic nerve sheath meningioma. <span class="figure-caption-bold">A,</span>&#160;A T1-weighted axial orbital MRI scan shows the normal hyperintense orbital fat. <span class="figure-caption-bold">B,</span>&#160;Suppression of the orbital fat allows visualization of the optic nerve sheath enhancement <span class="figure-caption-italic">(arrow)</span> consistent with a meningioma. <span class="figure-caption-bold">C,</span>&#160;A T1-weighted coronal postcontrast image with orbital fat suppression shows enhancement of the optic nerve sheath <span class="figure-caption-italic">(arrow).</span> <span class="figure-source-note">(Courtesy of Valerie Biousse, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer028" class="_idGenObjectStyleOverride-1">
			<p class="page-elements_rhv"> <span class="rh-bullet">●</span> Neuro-Ophthalmology</p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer031">
				<div id="_idContainer029" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-8</span> MRI scan from a 48-year-old woman who presented with slowly progressive decreased vision in the left eye. The T1-weighted axial postcontrast image with fat suppression shows a meningioma involving the middle cranial fossa of the skull base <span class="figure-caption-italic">(arrow),</span> including the optic canal. Abnormal enhancement in the orbital apex indicates that the meningioma extends along the optic nerve sheath <span class="figure-caption-italic">(arrowhead).</span> <span class="figure-source-note">(Courtesy of Eric E</span><span class="figure-source-note">g</span><span class="figure-source-note">&#173;genberger, DO.)</span></p>
				</div>
				<div id="_idContainer030" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00705.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer034">
				<div id="_idContainer032" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00756.png" alt="" />
				</div>
				<div id="_idContainer033" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-9</span> MRI scans of a 30-year-old woman with acute optic neuritis of the left eye. An axial FLAIR image&#160;<span class="figure-caption-bold">(A)</span> and an axial T2-weighted image&#160;<span class="figure-caption-bold">(B)</span> show bilateral, scattered, periventricular white-matter hyperintense lesions, which are more conspicuous on the FLAIR image. </p>
					<p class="figure-caption-cont-line"><span class="CharOverride-1">(Continued)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer037">
				<div id="_idContainer035" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN007561.png" alt="" />
				</div>
				<div id="_idContainer036" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-9 </span><span class="figure-number CharOverride-2">(continued)</span> <span class="figure-caption-bold">C,</span>&#160;A T2-weighted sagittal image demonstrates the same periventricular white matter changes perpendicular to the corpus callosum <span class="figure-caption-italic">(arrows),</span> also known as Dawson fingers. <span class="figure-caption-bold">D,</span>&#160;A T1-weighted coronal postcontrast image with orbital fat suppression shows enhancement of the left optic nerve <span class="figure-caption-italic">(arrow).</span> <span class="figure-source-note">(Courtesy of M.&#160;Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer040">
				<div id="_idContainer038" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00757.png" alt="" />
				</div>
				<div id="_idContainer039" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-10</span> Axial MRI scans demonstrate the value of DWI in acute infarction. <span class="figure-caption-bold">A,</span>&#160;The FLAIR image is normal except for nonspecific tiny foci of hyperintense signal in the deep white matter. <span class="figure-caption-bold">B,</span>&#160;DWI reveals abnormal restricted diffusion (high-&#173;intensity signal) near the left middle cerebral artery. <span class="figure-caption-bold">C,</span>&#160;The low-&#173;intensity signal on the ADC map is consistent with an acute infarction. <span class="figure-source-note">(Courtesy of M.&#160;Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer043">
				<div id="_idContainer041" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-5407.png" alt="" />
				</div>
				<div id="_idContainer042" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-11</span> A contrast angiogram, lateral view, demonstrates an aneurysm of the posterior communicating artery <span class="figure-caption-italic">(arrow).</span> ACA = anterior cerebral artery; ICA = internal carotid artery; MCA = middle cerebral artery. <span class="figure-source-note">(Courtesy of Rod Foroozan, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer046">
				<div id="_idContainer044" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00758.png" alt="" />
				</div>
				<div id="_idContainer045" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-12</span> Magnetic resonance angiography (MRA) provides excellent noninvasive information about large- and medium-&#173;size vessels. <span class="figure-caption-bold">A,</span>&#160;An MRA source image shows an abnormality at the junction of the posterior communicating artery and internal carotid artery <span class="figure-caption-italic">(arrow).</span> A volume-&#173;rendered 3-dimensional image&#160;<span class="figure-caption-bold">(B)</span> and a maximal intensity projection image&#160;<span class="figure-caption-bold">(C)</span> clearly show a posterior communicating artery aneurysm <span class="figure-caption-italic">(arrow</span><span class="figure-caption-italic">s</span><span class="figure-caption-italic">).</span> <span class="figure-source-note">(Courtesy of M.&#160;Tariq Bhatti, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer049">
				<div id="_idContainer047" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-9375.png" alt="" />
				</div>
				<div id="_idContainer048" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-13</span> Venous sinus thrombosis. <span class="figure-caption-bold">A,</span>&#160;Postcontrast axial CT scan shows a right-&#173;sided transverse sinus thrombosis <span class="figure-caption-italic">(arrows).</span> <span class="figure-caption-bold">B,</span>&#160;The magnetic resonance venography scan with contrast shows a complete thrombotic occlusion of the right transverse sinus <span class="figure-caption-italic">(arrows).</span> <span class="figure-source-note">(Courtesy of Paul&#160;H. Phillips, MD.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer050" class="Basic-Text-Frame">
			<table id="table004" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-25" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-4" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-26" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="5">
							<p class="table-title"><span class="table-number">Table 2-4</span> Imaging Choice Based on Clinical Scenario</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Clinical Scenario </p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Imaging Study</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Comments</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-27">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Acute hemorrhage</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">CT, MRI</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">CT better for acute subarachnoid hemorrhage; MRI clarifies evolution of intraparenchymal hemorrhage</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Aneurysm</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">MRA, CTA, angiography</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">May be missed by MRI and CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Arteriovenous malformation </p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Angiography</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Bone disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Calcification</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Most forms poorly visualized on MRI</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Carotid cavernous fistula</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRA, angiography</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRA prior to angiography</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Carotid dissection</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI, MRA, CTA</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Carotid stenosis</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Doppler, MRA, CTA, angiography</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Cerebral vascular disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRA, CTA, CTV</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Cerebral venous disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI, MRA, MRV</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Chiasmal syndrome</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI </p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Poorly visualized on CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Demyelination or multiple sclerosis </p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">FLAIR best for demyelinating lesions; poorly visualized on CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Foreign body</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI problematic with ferromagnetic objects, such as vascular clips</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Infection</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Abscess, meningitis</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Meningeal disorders</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI </p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Infectious, inflammatory, or neoplastic process</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Middle cranial fossa disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI, CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7" />
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Neoplasm</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI better for edema and features, less so for bony involvement</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Optic neuritis</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Include contrast and fat suppression; CT poor</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Orbitopathy</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI, CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Include fat suppression with MRI</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Paranasal sinus disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT, MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT shows bony details better than MRI</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Parasellar disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT: bony artifact</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Pituitary adenoma</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT in axial plane often misses pituitary abnormalities</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Posterior cranial fossa disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT: bony artifact</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Radiation damage</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Use contrast with MRI; poorly visualized on CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Thyroid eye disease</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI, CT, US</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">MRI should be done with orbital fat-suppression technique</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Trauma</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">CT</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Faster; shows acute blood and bony changes</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">White matter disease</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">MRI</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Poorly visualized on CT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-10" colspan="5">
							<p class="table-footnote ParaOverride-11">CT = computed tomography; CTA = computed tomography angiography; CTV = computed tomography venography; DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; MRA = magnetic resonance angiography; MRI = magnetic resonance imaging; MRV = magnetic resonance venography; US = ultrasonography.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer053">
				<div id="_idContainer051" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-6323.png" alt="" />
				</div>
				<div id="_idContainer052" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-14</span> A 19-year-old man was referred for&#160;evaluation of double vision following a motor vehicle accident. Examination revealed difficulty with adduction of the left eye and a narrowing of the palpebral fissure on attempted abduction of the same eye. Coronal CT&#160;scan demonstrates an entrapped left medial rectus muscle <span class="figure-caption-italic">(arrow).</span> <span class="figure-source-note">(Courtesy of Steven&#160;A. Newman, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer056">
				<div id="_idContainer054" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/KIN00924.png" alt="" />
				</div>
				<div id="_idContainer055" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-15</span> Delayed diagnosis of a right cranial nerve (CN) III schwannoma. <span class="figure-caption-bold">A,</span>&#160;Initial MRI results were negative, but fine cuts through the cavernous sinus demonstrated asymmetry, with a slight nodule in the superior portion of the cavernous sinus on the right. <span class="figure-caption-bold">B,</span>&#160;This area became bright following administration of gadolinium contrast, which indicated the presence of a right CN&#160;III schwannoma <span class="figure-caption-italic">(arrow).</span> <span class="figure-source-note">(Courtesy of Steven&#160;A. Newman, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer059">
				<div id="_idContainer057" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S05_ch02_p057-076-web-resources/image/AAX-5489.png" alt="" />
				</div>
				<div id="_idContainer058" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 2-16</span> A 41-year-old woman was referred for progressive vision loss in the right eye. She had been told she had a swollen optic nerve on the right; her condition was diagnosed as a “mild form of multiple sclerosis.” Her visual acuity was 2/200&#160;OD and 20/20&#160;OS, with a right relative afferent pupillary defect. She had reportedly had 2&#160;previous MRI scans, with negative results. <span class="figure-caption-bold">A,</span>&#160;A fundus photograph of the right optic nerve head demonstrates temporal pallor with optociliary shunt vessels. The patient was referred for a third MRI scan, but this study was misdirected for workup of “microvascular brainstem disease” and revealed no abnormalities. <span class="figure-caption-bold">B,</span>&#160;A sagittal MRI scan taken through the orbit shows an abnormal optic nerve sheath appearance consistent with an optic nerve sheath meningioma <span class="figure-caption-italic">(arrow).</span> The <span class="figure-caption-italic">arrowhead</span> points to the plaque portion of the meningioma. <span class="figure-source-note">(Part A courtesy of Steven&#160;A. Newman, MD; part&#160;B courtesy of Eric Eggenberger, DO.)</span></p>
				</div>
			</div>
		</div>
	</body>
</html>
